Ligand binding is a critical requirement for plasma membrane expression of heteromeric kainate receptors.
about
Pharmacological chaperoning: a primer on mechanism and pharmacologyStructure and Assembly Mechanism for Heteromeric Kainate ReceptorsGlutamate binding and conformational flexibility of ligand-binding domains are critical early determinants of efficient kainate receptor biogenesis.Glutamate receptor ion channels: structure, regulation, and functionContribution of the global subunit structure and stargazin on the maturation of AMPA receptorsGABA acts as a ligand chaperone in the early secretory pathway to promote cell surface expression of GABAA receptorsControl of assembly and function of glutamate receptors by the amino-terminal domain.The biochemistry, ultrastructure, and subunit assembly mechanism of AMPA receptors.Functional architecture of olfactory ionotropic glutamate receptors.Trafficking of kainate receptors.Interaction of the M4 segment with other transmembrane segments is required for surface expression of mammalian α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.Neuronal gamma-aminobutyric acid (GABA) type A receptors undergo cognate ligand chaperoning in the endoplasmic reticulum by endogenous GABA.Glutamate binding to the GluN2B subunit controls surface trafficking of N-methyl-D-aspartate (NMDA) receptorsPharmacological insights obtained from structure-function studies of ionotropic glutamate receptors.Glutamate receptors and endoplasmic reticulum quality control: looking beneath the surface.Chemical and pharmacological chaperones as new therapeutic agents.An overview of trafficking and assembly of neurotransmitter receptors and ion channels (Review).Agonist binding to the GluK5 subunit is sufficient for functional surface expression of heteromeric GluK2/GluK5 kainate receptors.The integrity of the glycine co-agonist binding site of N-methyl-D-aspartate receptors is a functional quality control checkpoint for cell surface delivery.Gating motions underlie AMPA receptor secretion from the endoplasmic reticulum.Aggregation Limits Surface Expression of Homomeric GluA3 Receptors.Cognate Ligand Chaperoning: a Novel Mechanism for the Post-translational Regulation of Neurotransmitter Receptor Biogenesis.Mapping the ligand binding sites of kainate receptors: molecular determinants of subunit-selective binding of the antagonist [3H]UBP310.Ligand-binding domain determines endoplasmic reticulum exit of AMPA receptorsTemporally precise single-cell-resolution optogenetics.Pharmacological Chaperones: Beyond Conformational Disorders.
P2860
Q27001695-DAAD6BC1-2729-4B4C-8288-6BEE9771B8F7Q27671015-990D3799-7215-468E-B386-835370AA0959Q27865232-9720E1BF-A151-4C1A-97B2-6864E6349D2EQ28290774-15B684DC-00D8-4F2C-A2A7-26566BE13A8CQ33743691-C431A0E6-6298-4808-8716-18F6F47771E9Q34140020-A450E7A8-B34C-4CB0-A9C9-8C9CDE9948E4Q34310112-2AF283EA-3767-4F5C-80D5-E61C7A581CF0Q34351420-4A038E5B-1F72-4537-933E-C421D2FF276FQ34630242-C1075E41-478E-4113-92A6-1180B4C2D7F5Q35228692-00DA219A-012F-426D-B8F7-A20EA7DE1013Q35562796-8E8F3305-0364-4007-9A25-B3048093208FQ35617513-171A11CE-7803-4ECA-8D63-956A3330FBC9Q36201847-76CC62D2-CE97-4A60-990E-88A6805623B3Q36394958-1070B88E-EC8A-4A95-86E9-E791A544B703Q36473601-75D4074F-5716-4B47-BB52-1A03596CB0DBQ36863386-A9CC5A52-88ED-4C7E-909F-30F431300BA7Q37150909-EFD18B6B-3D90-4342-A877-475609BB5D40Q37251208-1F70DC49-A6D7-4821-8DA9-6A79B56DF21BQ39920228-CBBAF366-6D51-4F45-9910-37DF10F229A0Q39928822-256FFEE2-5F88-427A-A62D-942FDB40267DQ41210310-C1F2E8F8-73CA-40AD-9BAF-7BDBB4B1AEC6Q41436788-916A6783-851A-4B4D-9069-3658E3FBADF5Q41452263-B165FE6C-08E2-4610-8803-FE82C6940BB1Q42087907-92682831-68F0-4AF0-BFCD-5634EEED00F0Q47305079-974C0B6B-64FF-4229-BFC6-0DCFC5B2E405Q47602237-45F8F824-BB36-47F6-99AA-A618E3BDD624
P2860
Ligand binding is a critical requirement for plasma membrane expression of heteromeric kainate receptors.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Ligand binding is a critical r ...... heteromeric kainate receptors.
@en
type
label
Ligand binding is a critical r ...... heteromeric kainate receptors.
@en
prefLabel
Ligand binding is a critical r ...... heteromeric kainate receptors.
@en
P2093
P2860
P356
P1476
Ligand binding is a critical r ...... heteromeric kainate receptors.
@en
P2093
Anis Contractor
Geoffrey T Swanson
Lokanatha Valluru
Yongling Zhu
P2860
P304
P356
10.1074/JBC.M411549200
P407
P577
2004-12-06T00:00:00Z